These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1838495)
1. Effects of chronic administration of MK-801 upon local cerebral glucose utilisation and ligand binding to the NMDA receptor complex. Kurumaji A; Ikeda M; Dewar D; McCormack AG; McCulloch J Brain Res; 1991 Nov; 563(1-2):57-65. PubMed ID: 1838495 [TBL] [Abstract][Full Text] [Related]
2. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats following unilateral lesion of caudal entorhinal cortex. Kurumaji A; McCulloch J Brain Res; 1990 Oct; 531(1-2):72-82. PubMed ID: 2289138 [TBL] [Abstract][Full Text] [Related]
3. Effects of NMDA antagonists, MK-801 and CPP, upon local cerebral glucose use. Kurumaji A; Nehls DG; Park CK; McCulloch J Brain Res; 1989 Sep; 496(1-2):268-84. PubMed ID: 2553203 [TBL] [Abstract][Full Text] [Related]
4. Comparison of the patterns of altered cerebral glucose utilisation produced by competitive and non-competitive NMDA receptor antagonists. Sharkey J; Ritchie IM; Butcher SP; Kelly JS Brain Res; 1996 Sep; 735(1):67-82. PubMed ID: 8905171 [TBL] [Abstract][Full Text] [Related]
5. Quantitative autoradiographic characterization of the binding of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10-imine ([3H]MK-801) in rat brain: regional effects of polyamines. Subramaniam S; McGonigle P J Pharmacol Exp Ther; 1991 Feb; 256(2):811-9. PubMed ID: 1671602 [TBL] [Abstract][Full Text] [Related]
6. Characterization of spermidine-dependent [3H](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801) binding in brain synaptic membranes treated with Triton X-100. Yoneda Y; Ogita K; Enomoto R J Pharmacol Exp Ther; 1991 Mar; 256(3):1161-72. PubMed ID: 1826032 [TBL] [Abstract][Full Text] [Related]
7. Heterogeneity of the N-methyl-D-aspartate receptor ionophore complex in rat brain, as revealed by ligand binding techniques. Yoneda Y; Ogita K J Pharmacol Exp Ther; 1991 Oct; 259(1):86-96. PubMed ID: 1681092 [TBL] [Abstract][Full Text] [Related]
8. Differential effects of competitive and non-competitive N-methyl-D-aspartate antagonists on glucose use in the limbic system. Nehls DG; Kurumaji A; Park CK; McCulloch J Neurosci Lett; 1988 Aug; 91(2):204-10. PubMed ID: 2847086 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of competitive (CGS19755) and non-competitive (MK 801) NMDA receptor antagonists upon local cerebral blood flow and local cerebral glucose utilisation in the rat. Sharkey J; Ritchie IM; Butcher SP; Kelly JS Brain Res; 1994 Jul; 651(1-2):27-36. PubMed ID: 7922575 [TBL] [Abstract][Full Text] [Related]
10. Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function. Duncan G; Miyamoto S; Gu H; Lieberman J; Koller B; Snouwaert J Brain Res; 2002 Oct; 951(2):166-76. PubMed ID: 12270494 [TBL] [Abstract][Full Text] [Related]
12. Effects of MK-801 upon local cerebral glucose utilisation in conscious rats and in rats anaesthetised with halothane. Kurumaji A; McCulloch J J Cereb Blood Flow Metab; 1989 Dec; 9(6):786-94. PubMed ID: 2684992 [TBL] [Abstract][Full Text] [Related]
13. Lack of effect of L-687,414 ((+)-cis-4-methyl-HA-966), an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Hargreaves RJ; Rigby M; Smith D; Hill RG Br J Pharmacol; 1993 Sep; 110(1):36-42. PubMed ID: 8220897 [TBL] [Abstract][Full Text] [Related]
14. Lead-induced changes in NMDA receptor complex binding: correlations with learning accuracy and with sensitivity to learning impairments caused by MK-801 and NMDA administration. Cory-Slechta DA; Garcia-Osuna M; Greenamyre JT Behav Brain Res; 1997 May; 85(2):161-74. PubMed ID: 9105573 [TBL] [Abstract][Full Text] [Related]
15. Blockade of NMDA receptor-channels by MK-801 alters breathing in adult rats. Connelly CA; Otto-Smith MR; Feldman JL Brain Res; 1992 Nov; 596(1-2):99-110. PubMed ID: 1468006 [TBL] [Abstract][Full Text] [Related]
16. Competitive (AP7) and non-competitive (MK-801) NMDA receptor antagonists differentially alter glucose utilization in rat cortex. Clow DW; Lee SJ; Hammer RP Synapse; 1991 Apr; 7(4):260-8. PubMed ID: 1828310 [TBL] [Abstract][Full Text] [Related]
17. The effects of N-methyl-D-aspartate receptor blockade with MK-801 upon the relationship between cerebral blood flow and glucose utilisation. Nehls DG; Park CK; MacCormack AG; McCulloch J Brain Res; 1990 Mar; 511(2):271-9. PubMed ID: 2159360 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of [3H]-(+)-MK 801 binding to rat brain sections by CPP and 7-chlorokynurenic acid: an autoradiographic analysis. Tacconi S; Ratti E; Marien MR; Gaviraghi G; Bowery NG Br J Pharmacol; 1993 Mar; 108(3):577-82. PubMed ID: 8096780 [TBL] [Abstract][Full Text] [Related]
19. Regional alterations in brain amino acids after administration of the N-methyl-D-aspartate receptor antagonists MK-801 and CGP 39551 in rats. Löscher W; Hönack D; Fassbender CP Neurosci Lett; 1991 Mar; 124(1):115-8. PubMed ID: 1677457 [TBL] [Abstract][Full Text] [Related]
20. Effects of unilateral intrahippocampal injection of MK-801 upon local cerebral glucose utilisation in conscious rats. Kurumaji A; McCulloch J Brain Res; 1990 Jun; 518(1-2):342-6. PubMed ID: 2202490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]